Skip to content
OpenCapital
Get started

Clover Health Investments CLOV Long-term marketable securities

Long-term marketable securities at other companies

Elevance Health logo
Elevance HealthELV
$1.11B+5.1%
Humana logo
HumanaHUM
——

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05—

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%—

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0×0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's long-term marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's long-term marketable securities?
Clover Health Investments (CLOV) reported long-term marketable securities of $202.24M in Q1 2026.
How has Clover Health Investments's long-term marketable securities changed year-over-year?
Clover Health Investments's long-term marketable securities decreased by 6.6% year-over-year, from $216.51M to $202.24M.
What is the long-term trend for Clover Health Investments's long-term marketable securities?
Over 5 years (2020 to 2025), Clover Health Investments's long-term marketable securities has grown at a 28.2% compound annual growth rate (CAGR), from $53.96M to $187.09M.